Current position:Home >Product >
2-{[1-(trans-4-methylcyclohexyl)-1H-imidazol-4-yl]methyl}-5-(L-norleucylamino)valeric acid
2-{[1-(trans-4-methylcyclohexyl)-1H-imidazol-4-yl]methyl}-5-(L-norleucylamino)valeric acid(1335138-65-2)
- Name: 2-{[1-(trans-4-methylcyclohexyl)-1H-imidazol-4-yl]methyl}-5-(L-norleucylamino)valeric acid
- Synonyms:
- Molecular Formula:
- Molecular Weight:406.569
- CAS Registry Number:1335138-65-2
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 1056188-18-1/(5-amino-2-methyl-phenyl)-[2-chloro-4-(2-chloro-4-fluoro-phenylamino)-phenyl]-methanone
- 332120-99-7/3-(3-aminomethyl-cyclohexylmethyl)-2-(4-methylphenyl)-3H-quinazolin-4-one
- 344290-25-1/3-Mesityl-8-(2-methoxyethyl)-7-(3-methoxypropyl)-2,5-dimethyl-8H-pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidine
- 445452-97-1/N-[2-(2,3-DIHYDRO-1H-BENZO[DE]ISOQUINOLIN-2-YL)-6-(1-PIPERIDINYL)-4-PYRIMIDINYL]-N-(4-METHYLPHENYL)AMINE
- 355847-47-1/N-Hydroxy-2-[(S)-7-(4-(4-chlorophenoxy)phenyl)-4-(3-thiophenecarbonyl)-1,1-dioxoperhydro-1,4-thiazepin-7-yl]acetamide
- 258868-04-1/(2R,3S) N1-[6,7-dihydro-5-(3-phenoxybenzyl)-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2-(cyclobutylmethyl)-3-(butyl)-butanediamide
- 258866-45-4/(2R,3S) N1-[1,3-dihydro-1-(3-(4-methylphenyl)benzyl)-2-oxo-5-(phenyl)-2H-1,4-benzodiazepin-3-yl]-2-(cyclopropylmethyl)-3-(butyl)-butanediamide
- 209481-80-1/(S)-5-Chloro-3-methylbenzo[b]thiophene-2-sulfonic Acid[4-Methoxy-3-(1-methylpyrrolidin-2-ylmethoxy)phenyl]amide
- 263390-48-3/2-(3-fluorophenylthio)-3-pyridinol
- 51632-10-1/[3-(2-thienyloxy)phenyl]methanol
- 335381-89-0/(2S,3S,4R)-N-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-([1,3]dioxolan-2-yl)-2H-benzopyran-4-yl)-N'-benzylguanidine
- 151135-65-8/2,4-diethoxy-4'-hydroxy-chalcone
- 146285-37-2/4-pyrrolidinopyridinium-N-(4-chloro-2-fluoro-5-methoxycarbonyl-methylthiophenyl)dithiocarbamate
- 145691-26-5/3-{3-[2-(3-Methylbutanoylamino)ethyl]-5-(3-pyridylmethyl)phenyl}propanoic acid
- 173900-79-3/N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[5-(3-cyclopentylpropyl)-[1,2,4]-oxadiazol-3-yl]benzensulfonamide
- 137014-62-1/triethylammonium salt of 4-hydroxy-3-(4-methylsulfonyl-2-nitrobenzoyl)-bicyclo-[3.2.1]-3-octen-2-one
- 178817-82-8/[[4-[1,4-Dioxo-4-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)butan-1-yl]-1,2-phenylene]dioxy]diacetic acid trifluoroacetate
- 913296-19-2/4-(6-(2-(cyclohexylmethylamino)-4-(trifluoromethyl)phenyl)pyrimidin-4-ylamino)-2,3-dihydro-1H-inden-1-ol
- 1415090-81-1/N,N-dibutyl-4-chloro-1-(4-(1-(2-(3,4-dichlorophenyl)acetyl)indolin-5-ylsulfonylcarbamoyl)-2-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)phenyl)-5-methyl-1H-pyrazole-3-carboxamide
- 1335138-65-2/2-{[1-(trans-4-methylcyclohexyl)-1H-imidazol-4-yl]methyl}-5-(L-norleucylamino)valeric acid
- 1419215-30-7/4-(8-amino-3-(6-isobutyryl-6-azaspiro[2.5]octan-1-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
- 1422424-17-6/C24H24FN3O3
- 1428251-28-8/5-vinyl-6-{4-[4-(3-fluorophenyl)-1-(2-pyrrolidin-1-ylethyl)-1H-imidazol-2-yl]piperidin-1-yl}pyrimidin-4-ylamine
- 1429654-70-5/3-bromo-2-(3,4-difluorophenyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole
- 1438421-56-7/5-(6-((1R,2S)-2-aminocyclohexylamino)-3-carbamoylpyrazin-2-ylamino)-N,N-dimethylisothiazole-3-carboxamide
- 1429025-55-7/5-(2-(3-chloro-[1,2,4]triazolo[4,3-b]pyridazin-6-yloxy)-4-(trifluoromethyl)phenyl)pyridin-3-ol
- 1442118-97-9/2-{[1-(4-chlorobenzoyl)piperidin-4-yl]methyl}-4-ethyl-N-(2-methoxyethyl)-2H-indazole-5-carboxamide
- 1446444-30-9/4-{[5-chloro-6-(cyclopropylamino)pyridin-3-yl]oxy}-N-[(dimethylamino)sulfonyl]-2,5-difluorobenzamide formate salt
- 1450898-96-0/triphenylstannyl 3-(1H-benzimidazol-2-yl)propanoate(THF)
- 1404560-25-3/N-(2-amino-5-(pyridin-4-yl)phenyl)-1-methyl-2-oxopiperidine-4-carboxamide
